Is BridgeBio Pharma, Inc. overvalued?

BridgeBio Pharma, Inc. (BBIO) — key valuation metrics and fundamentals.

No verdict

Price

$65.57

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$12.84B

Dividend yield

0.0%

Return on equity

31.7%

Sector

Healthcare

Fair value compares BBIO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks